학술논문
Consumer and Healthcare Professional Led Priority Setting for Quality Use of Medicines in People with Dementia: Gathering Unanswered Research Questions.
Document Type
Academic Journal
Author
Reeve E; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.; Geriatric Medicine Research, Faculty of Medicine and College of Pharmacy, Dalhousie University and Nova Scotia Health Authority, Halifax, NS, Canada.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.; Chenoweth L; Centre for Healthy Brain Ageing, University of New South Wales, Kensington, NSW, Australia.; Sawan M; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.; School of Pharmacy, University of Sydney, Sydney, NSW, Australia.; Nguyen TA; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.; National Ageing Research Institute, Parkville, VIC, Australia.; School of Health Sciences, Swinburne University of Technology, Melbourne, VIC, Australia.; Health Strategy and Policy Institute, Ministry of Health of Vietnam, Hanoi, Vietnam.; Kalisch Ellett L; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.; Gilmartin-Thomas J; Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC, Australia.; Tan E; School of Pharmacy, University of Sydney, Sydney, NSW, Australia.; Sluggett JK; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.; UniSA Allied Health and Human Performance, University of South Australia, Adelaide, SA, Australia.; Quirke LS; Consumer advocate, Dementia Australia, Sydney, NSW, Australia.; Tran K; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.; National Ageing Research Institute, Parkville, VIC, Australia.; School of Health Sciences, Swinburne University of Technology, Melbourne, VIC, Australia.; Health Strategy and Policy Institute, Ministry of Health of Vietnam, Hanoi, Vietnam.; Ailabouni N; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.; Pharmacy Australia Centre of Excellence, Health and Behavioural Science Department, School of Pharmacy, University of Queensland, Brisbane, QLD, Australia.; Cowan K; James Lind Alliance, University of Southampton, Southampton, UK.; Sinclair R; Consumer advocate, Dementia Australia, Sydney, NSW, Australia.; de la Perrelle L; College of Education, Psychology and Social Work, Flinders University, SA, Australia.; College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.; Deimel J; Central Adelaide Local Health Network (CALHN) Memory Service, Adelaide, SA, Australia.; To J; Division of Aged Care, Rehabilitation and Palliative Care, Northern Adelaide Local Health Network, Adelaide, SA, Australia.; Daly S; Family Health Medical Group, Adelaide, SA, Australia.; Sensus Cognition, Adelaide, SA, Australia.; Whitehead C; Division of Rehabilitation, Aged and Palliative Care, Southern Adelaide Local Health Network, SA Health, Adelaide, SA, Australia.; Hilmer SN; Kolling Institute of Medical Research, Northern Clinical School, Faculty of Medicine and Health, University of Sydney and Royal North Shore Hospital, St Leonards, NSW, Australia.
Source
Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9814863 Publication Model: Print Cited Medium: Internet ISSN: 1875-8908 (Electronic) Linking ISSN: 13872877 NLM ISO Abbreviation: J Alzheimers Dis Subsets: MEDLINE
Subject
Language
English
Abstract
Background: Historically, research questions have been posed by the pharmaceutical industry or researchers, with little involvement of consumers and healthcare professionals.
Objective: To determine what questions about medicine use are important to people living with dementia and their care team and whether they have been previously answered by research.
Methods: The James Lind Alliance Priority Setting Partnership process was followed. A national Australian qualitative survey on medicine use in people living with dementia was conducted with consumers (people living with dementia and their carers including family, and friends) and healthcare professionals. Survey findings were supplemented with key informant interviews and relevant published documents (identified by the research team). Conventional content analysis was used to generate summary questions. Finally, evidence checking was conducted to determine if the summary questions were 'unanswered'.
Results: A total of 545 questions were submitted by 228 survey participants (151 consumers and 77 healthcare professionals). Eight interviews were conducted with key informants and four relevant published documents were identified and reviewed. Overall, analysis resulted in 68 research questions, grouped into 13 themes. Themes with the greatest number of questions were related to co-morbidities, adverse drug reactions, treatment of dementia, and polypharmacy. Evidence checking resulted in 67 unanswered questions.
Conclusion: A wide variety of unanswered research questions were identified. Addressing unanswered research questions identified by consumers and healthcare professionals through this process will ensure that areas of priority are targeted in future research to achieve optimal health outcomes through quality use of medicines.
Objective: To determine what questions about medicine use are important to people living with dementia and their care team and whether they have been previously answered by research.
Methods: The James Lind Alliance Priority Setting Partnership process was followed. A national Australian qualitative survey on medicine use in people living with dementia was conducted with consumers (people living with dementia and their carers including family, and friends) and healthcare professionals. Survey findings were supplemented with key informant interviews and relevant published documents (identified by the research team). Conventional content analysis was used to generate summary questions. Finally, evidence checking was conducted to determine if the summary questions were 'unanswered'.
Results: A total of 545 questions were submitted by 228 survey participants (151 consumers and 77 healthcare professionals). Eight interviews were conducted with key informants and four relevant published documents were identified and reviewed. Overall, analysis resulted in 68 research questions, grouped into 13 themes. Themes with the greatest number of questions were related to co-morbidities, adverse drug reactions, treatment of dementia, and polypharmacy. Evidence checking resulted in 67 unanswered questions.
Conclusion: A wide variety of unanswered research questions were identified. Addressing unanswered research questions identified by consumers and healthcare professionals through this process will ensure that areas of priority are targeted in future research to achieve optimal health outcomes through quality use of medicines.